Higher blood levels of omega-3 fatty acids from prescription fish oil showed no effect on CV events
Stair climbing offers significant cardiovascular and muscular benefits for heart patients
17 May 2021New study of how US recreational cannabis legalization could change illegal drug markets
17 May 2021Higher blood levels of omega-3 fatty acids from prescription fish oil showed no effect on CV events
Patients at high risk for cardiovascular events who had the highest levels of eicosapentaenoic acid (EPA) in their blood one year after taking daily omega-3 carboxylic acid, a prescription-grade fish oil, had similar rates of major cardiovascular events as people taking a corn oil placebo, according to a secondary analysis of the STRENGTH trial presented at the American College of Cardiology’s 70th Annual Scientific Session. Researchers also found no increase in cardiovascular events among patients with the highest levels of docosahexaenoic acid (DHA) compared to placebo.
